The Healing Company Inc.

HLCO · OTC
Analyze with AI
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Valuation
PEG Ratio-0.00-4.370.00-103.73
FCF Yield-3.27%-1.60%-0.01%-0.04%
EV / EBITDA-12.69-1,150.950.000.00
Quality
ROIC-751.80%129.70%1.38%221.42%
Gross Margin22.37%0.00%0.00%0.00%
Cash Conversion Ratio0.370.320.010.79
Growth
Revenue 3-Year CAGR
Free Cash Flow Growth-215.45%-21,747.04%42.11%-1.79%
Safety
Net Debt / EBITDA-0.1845.890.000.00
Interest Coverage-36.23-48.630.000.00
Efficiency
Inventory Turnover2.580.000.000.00
Cash Conversion Cycle-95.660.000.000.00